Indoco Pharmchem Limited, a struck off public limited company, was established on 26 June 2012 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U33112MH2012PLC232609. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Its leadership includes Sundeep Vasant Bambolkar (Director), Aditi Milind Panandikar (Director), Suresh Govind Kare (Director). Its latest AGM occurred on 08 August 2017, with the balance sheet filed on 31 March 2017. It is based at Indoco House 166 Cst Road Santacruz East, Mumbai, Maharashtra, 400098.
U33112MH2012PLC232609
232609
26 June 2012
₹0.50 M
₹0.50 M
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Indoco Pharmchem Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sundeep Vasant Bambolkar | Director | 26 Jun 2012 | Current |
| Aditi Milind Panandikar | Director | 26 Jun 2012 | Current |
| Suresh Govind Kare | Director | 26 Jun 2012 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Indoco Pharmchem Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 12.07% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Indoco Pharmchem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Indoco Pharmchem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Indoco Pharmchem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indoco Pharmchem's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Indoco Pharmchem Limited last Annual general meeting of members was held on 08 Aug 2017 as per latest MCA records. was documented.
The activity Indoco Pharmchem Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Mumbai. was completed.
The activity Sundeep Vasant Bambolkar was appointed as a Director was appointed as a Director on 26 Jun 2012 & has been associated with this company since 13 years 5 months . was completed.
The activity Aditi Milind Panandikar was appointed as a Director was appointed as a Director on 26 Jun 2012 & has been associated with this company since 13 years 5 months . was completed.
The activity Suresh Govind Kare was appointed as a Director was appointed as a Director on 26 Jun 2012 & has been associated with this company since 13 years 5 months . was completed.
Indoco Pharmchem Limited was registered on 26 Jun 2012 with Roc Mumbai & aged 13 years 5 months as per MCA records. was recorded as a recent event.
Indoco Remedies Q3 FY24 Results Live : Revenue increased by 15.09% YoY & profit decreased by 42.08% YoY.
Indoco Remedies gets USFDA approval for Parkinson's drug. First approval since warning letter in 2017. 32 more pending. Market size: $105 million. Stock up 5.38%..
The inspection by UK health regulator, MHRA were held from September 16-20, 2019 and resulted in 2 observations, Indoco Remedies said in a regulatory filing..
Indoco Remedies' Goa facility gets full GMP status from UK health regulator. Now they can sell their meds in Europe faster. UK inspected in 2018 and gave restricted GMP cert, but after more audits, now full GMP status. Goa Plant I makes pills, liquids, and creams. Stock up 5.27%..
The CIN of Indoco Pharmchem Limited is U33112MH2012PLC232609.
Indoco Pharmchem Limited is headquartered at Indoco House 166 Cst Road Santacruz East, Mumbai, Maharashtra, 400098.
Indoco Pharmchem Limited was incorporated on 26 June 2012.
The current directors of Indoco Pharmchem Limited are
The primary industry of Indoco Pharmchem Limited is Pharma.
Indoco Pharmchem Limited is unlisted.
The authorized capital of Indoco Pharmchem Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX